Latest news with #MankindPharma
Time of India
25-06-2025
- Business
- Time of India
Nimulid Strong appoints Rajkummar Rao as its new brand ambassador
Mankind Pharma , India's pharmaceutical company, has announced actor Rajkummar Rao as the new brand ambassador for its flagship brand, Nimulid Strong for Pain Relief Gel and Spray. This strategic partnership aims to firmly establish Nimulid Strong as the trusted " Neck Pain Specialist " for targeted pain relief, highlighting its remarkable ability to provide relief in just two minutes, while leveraging Rao's relatable appeal and the product's powerful 2X Diclofenac formulation . Rao, celebrated for his versatile roles in critically acclaimed and commercially successful films embodies the spirit of those who refuse to let pain dictate their lives, the company stated in a press release. His genuine connection with everyday individuals makes him the perfect choice to represent Nimulid Strong, a brand committed to empowering people to overcome challenges and lead pain-free lives , it added. "We're absolutely thrilled to welcome Rajkummar Rao to the Mankind Pharma family, representing Nimulid Strong. Rajkummar's authenticity, relatability, and incredible craft resonate deeply with our audience, making him the ideal choice to represent Nimulid Strong – 'The Neck Pain Specialist,'' said Joy Chatterjee, vice president, sales and marketing head, consumer business unit, Mankind Pharma. 'Our mission is to empower individuals to overcome these challenges and lead pain-free lives, and with Nimulid Strong, they can experience relief in as little as two minutes. With Rajkummar on board, we're confident we'll strengthen Nimulid Strong's position as a trusted and highly effective solution for quick, localised relief,' Chatterjee added. Rao shared his thoughts on this association, stating, "I'm excited to be a part of the Mankind Pharma family and to endorse a brand like Nimulid Strong that offers such effective and quick relief, helping people get back to their lives without pain holding them back." This partnership underscores Mankind Pharma's dedication to providing fast and effective solutions for contemporary pain, particularly neck pain caused by digital fatigue, poor posture, and muscle stress, the company stated.
Time of India
13-06-2025
- Health
- Time of India
HealthOK pays tribute to tireless fathers in its Father's Day campaign
Mankind Pharma , India's pharmaceutical company, has launched a new Father's Day campaign for its flagship brand HealthOK pure vegetarian multivitamin tablets. This initiative celebrates fathers across the nation who demonstrate unwavering dedication to their responsibilities without ever getting tired. The campaign positions fathers as " HealthOK Heroes " – real-life superheroes who provide unconditional support to their families especially children while maintaining their energy and enthusiasm for parenthood. Joy Chatterjee, vice president, sales and marketing head, consumer business unit, Mankind Pharma, said, "Our campaign acknowledges that today's fathers seamlessly transition between multiple roles; they are providers who ensure family security, protectors who offer safety, mentors who guide with wisdom, and friends who share in life's joys.' The Father's Day campaign will be backed by a marketing push across digital and traditional platforms. The company stated that HealthOK celebrates the strength of every father and the potential of every child — because when kids are healthier, fathers are happier. Watch the video here:
Time of India
11-06-2025
- Entertainment
- Time of India
This Father's Day, Prega News honours the 'invisible journey' of fathers
HighlightsPrega News, a pregnancy detection kit brand from Mankind Pharma, launched a Father's Day campaign that emphasizes the often-overlooked contributions of expectant fathers during the pregnancy journey. The campaign features stand-up comedian Aashish Solanki portraying an expectant father who humorously attempts to experience the physical challenges of pregnancy, while also highlighting the emotional and practical support that fathers provide. Recent research shows that 95 percent of Indian fathers believe parenting is a shared responsibility, with 94 percent actively participating in household chores and childcare, reflecting a significant shift in traditional gender roles. Prega News , India's pregnancy detection kit brand from Mankind Pharma , has launched a new Father's Day campaign that celebrates the often-overlooked contributions of expectant fathers during the pregnancy journey. The campaign highlights how pregnancy transforms both partners' lives, even when one's journey remains largely invisible to the world. The campaign film features stand-up comedian Aashish Solanki as an expectant father who attempts to experience pregnancy by wearing a belly for a day, undertaking challenges that pregnant women face daily. From picking up objects to sitting comfortably during work calls, the humorous yet enlightening exercise reveals the physical difficulties expectant mothers endure. However, the narrative takes a meaningful turn when his pregnant wife Rashi and her friends arrive, shifting the focus to acknowledge the emotional and practical support that fathers provide throughout the pregnancy journey. "This Father's Day, we wanted to shine a light on the invisible half of pregnancy - the father's journey," said Joy Chatterjee, vice president, sales and marketing head, consumer business unit, Mankind Pharma. 'While the physical changes of pregnancy are visible in mothers, fathers too undergo a significant emotional transformation, taking on the responsibility of ensuring financial security for the growing family, working tirelessly to meet increased household needs, and making countless sacrifices to prepare for parenthood.' The campaign draws inspiration from recent research indicating that 95 per cent of Indian fathers believe that parenting is a shared responsibility, reflecting the evolving dynamics of modern Indian families . This progressive outlook marks a significant departure from traditional gender roles, with 94 per cent of fathers actively participating in household chores and childcare. "Through this campaign, we want to honour the countless ways fathers contribute to the pregnancy journey; from making late-night food runs, planning budgets and providing emotional stability to making major life adjustments and long-term planning for their child's education and healthcare,"Chatterjee added. The film concludes with the powerful message: "Prega News wishes a Happy Father's Day to all the amazing dads whose invisible journey may not be visible, but who stand by their partners through every joy and challenge of parenthood that begins with good news." Watch the video here:
Business Standard
10-06-2025
- Business
- Business Standard
Mankind Pharma allots 57,709 equity shares under ESOP
Mankind Pharma has allotted 57,709 equity shares of face value of Re. 1/- each of the Company to the eligible employees who have exercised their options pursuant to the ESOP Plan. Consequent to the aforesaid allotment, the paid-up share capital of the Company has increased from 41,26,71,039 equity shares to 41,27,28,748 equity shares having face value of Re. 1/- each. Powered by Capital Market - Live News
Mint
30-05-2025
- Health
- Mint
India to introduce more advanced testing for imported blood products to reduce infection risk
New Delhi: The health ministry plans to mandate the use of a faster and more accurate method to test all imported blood products to maintain the highest safety standards and reduce the risk of infection from transfusions. The ministry intends to introduce nucleic acid testing (NAT) to improve the screening of imported blood products for antibodies of the human immunodeficiency virus (HIV), the hepatitis B virus, the hepatitis C virus and other impurities, an official aware of the matter said. The decision to shift to NAT has already been taken by the regulator, the Drug Controller General of India (DCGI), and the matter was discussed at the Drugs Technical Advisory Board meeting in April. The board is the highest statutory body responsible for advising the Central and state governments on technical matters related to the administration of the Drugs and Cosmetics Act, 1940. Also Read | Banking on blood: Health ministry frames guidelines to curb paid donations, improve efficacy of transfusions With the introduction of NAT, the conventional testing method known as ELISA, or enzyme-linked immunosorbent assay, will be done away with. ELISA, while a powerful tool, has several drawbacks, including the potential for false positive and negative results, apart from being time-consuming. The Department of Pharmaceuticals and the National Institute of Biologicals (NIB) in Noida had issued an alert in October after the NIB found three imported blood products—Berirab-P (used in rabies injections), Hepabig (to prevent hepatitis B virus infection) and Tetglob (used for tetanus treatment)—to be of sub-standard quality. When the Berirab-P and Hepabig samples were tested again at the National Institute of Virology in Pune using an advanced version of polymerase chain reaction, which is more sensitive than ELISA, they passed the test metrics. The set of Tetglob samples sent to a private laboratory that used ELISA were non-reactive. Safety standards Bharat Serums and Vaccines Ltd, now owned by Mankind Pharma, is the only company in the country that imports these lifesaving blood products. Imported blood products are used for the treatment of critically ill patients or those who are suffering thalassemia and other blood-related disorders. These products are tested at government laboratories to ensure they meet safety and quality standards. Also Read | India plans standard evaluation and quality protocols for HMPV' testing kits 'These are tested using conventional methods, but now the plan is to amend the rules to allow an advanced version of testing in line with international practices," the official said. 'NIB also proposed that an amendment may be considered to test blood products by NAT." Queries sent to the health ministry, the Department of Pharmaceuticals and the Mankind Pharma spokesperson remained unanswered till press time. 'NAT testing gives accurate and quick results and nowadays it is highly used. NAT testing is used for tuberculosis and NAT testing was modified during the covid-19 pandemic to detect the coronavirus," a scientist from the Indian Council of Medical Research said, requesting anonymity. 'The ELISA test may sometimes give false results if the viral load in the sample is low. However, PCR and NAT give accurate results even if the viral load is low." Also Read | ICMR and CDSCO develop framework for validation of pathogen identification and antimicrobial susceptibility testing According to an assessment by the National Blood Transfusion Council, the apex policymaking body for issues pertaining to blood and plasma, the clinical requirement of blood in the country is about 14.5 million units per year. The volume of each unit of blood is about 450 ml. In India, the import, manufacture, distribution and sale of drugs, cosmetics and notified medical devices are regulated by the Drugs and Cosmetics Act and the Drugs and Cosmetics Rules, 1945.
